Latest Corporate Governance News

Page 1 of 300
BCAL Diagnostics is prepared to support an expedited Genetic Signatures and Microba merger, but only on revised terms, a GSS board reset and protections for a superior proposal. It may also provide up to $2 million in working capital to Microba, subject to raising the funds itself.
Ada Torres
Ada Torres
19 Nov 2026
Shaver Shop delivered record FY26 sales and gross profit, but rising wages, leases and online costs kept net profit broadly flat. Early FY27 trading remains softer, with like-for-like sales down 2.8% and no full-year guidance provided.
Logan Eniac
Logan Eniac
19 Nov 2026
West Cobar Metals has been suspended from quotation after confirming it lacks enough directors to meet Corporations Act requirements. The suspension will remain until ASX is satisfied that the company has restored compliance and is suitable for reinstatement.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Worley has reaffirmed mid to high single-digit growth expectations for FY2027 despite a weaker FY2026, while shareholders delivered a strong protest vote on executive remuneration. The AGM also began the search for a successor to long-serving Chair John Grill.
Victor Sage
Victor Sage
19 Nov 2026
Northern Star says KCGM commissioning is improving but remains beset by interruptions, with November availability at 72% and throughput up 15%. The update also puts the company’s rejected Gold Fields approach back in focus as new chief executive Suresh Vadnagra promises tighter operational and capital discipline.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Genetic Signatures has ended its proposed merger with Microba Life Sciences after Microba said it could not complete the transaction without raising more capital. The decision also removes the deal’s shareholder vote and leaves a Takeovers Panel application awaiting clarification.
Ada Torres
Ada Torres
18 Nov 2026
Home Depot is changing its top leadership team just as third-quarter sales and comparable-store growth accelerate. Richard McPhail will become CEO, while Ted Decker returns from medical leave to chair the board and the retailer trims its fiscal 2026 earnings outlook to modest growth.
Logan Eniac
Logan Eniac
17 Nov 2026
Aspermont has told ASX that directors John Stark and Graeme McCracken failed to obtain prior approval or notify the company of transactions, leading to late Appendix 3Y notices. ASX raised possible listing rule and Corporations Act breaches, although no penalty or formal finding has been disclosed.
Victor Sage
Victor Sage
17 Nov 2026
Tuas subsidiary Simba Telecom has acknowledged unauthorised use of multiple Singapore spectrum bands, 5G indoor equipment and a breach of a document production order. The regulatory response now includes proposed board changes, but IMDA has yet to make or confirm findings.
Sophie Babbage
Sophie Babbage
17 Nov 2026
Sanford delivered record FY26 earnings and cut net debt by 43%, but the result was powered by an unusually strong squid catch and a sharp fall in mussel profitability. The NZX-listed seafood group is now betting its strengthened balance sheet can support growth in mussels without surrendering its cost discipline.
Victor Sage
Victor Sage
17 Nov 2026
Moderna’s chief legal officer will retire in March under an agreement that provides US$1.63 million in fixed severance and up to US$8 million linked to litigation outcomes. The package also preserves her salary, benefits and equity vesting through her departure date.
Ada Torres
Ada Torres
14 Nov 2026
Genetic Signatures’ proposed Microba merger faces a formal challenge from 18.46% shareholder BCAL Diagnostics, which alleges the process lacks adequate protections and information for GSS investors. The Takeovers Panel has not yet appointed a sitting Panel or decided whether to open proceedings.
Ada Torres
Ada Torres
13 Nov 2026

Browse the archive

Full archive